| Page | ||
|---|---|---|
| Trustees' | annual report |
|
| Independent examiner's report to the trustees |
||
| Statement | offinancial activities |
|
| Statement | offinancial position |
|
| Statement | ofcash flows | |
| Notes to the financial statements |
| Reference a | nd adm | inistrative | details | |
|---|---|---|---|---|
| Registered | charity | name | Medical and Life Sciences Research | Fund |
| Charity registration | number | 1139383 | ||
| Principal office | Medical and Life Sciences Research | Fund | ||
| University ofWarwick Science Park |
||||
| Barclays Venture Centre | ||||
| Sir William Lyons Road |
||||
| Coventry | ||||
| The trustees | Prof C G Dowson | |||
| Dr A Shehu | ||||
| Dr C G Fink | ||||
| Dr M Atkins | ||||
| Independent | examiner | Mr KC Varney - ACMA ofVarney Barfield &Co. 6 Corunna Court |
||
| Corunna Road |
||||
| Warwick | ||||
| CV34 5HQ |
| Ye | ar en | ded 5April 2 | 021 | ||||
|---|---|---|---|---|---|---|---|
| 2021 | 2020 | ||||||
| Unrestricted | Restricted | ||||||
| funds | funds | Total funds | Total funds | ||||
| Note | |||||||
| Income and endowments | |||||||
| Donations and legacies |
4 | 484,606 | 16,000 | 500,606 | 73,270 | ||
| Total income | 484,606 | 16,000 | 500,606 | 73,270 | |||
| Expenditure | |||||||
| Expenditure on raising funds: |
|||||||
| Costs of raising donations | and | ||||||
| legacies Expenditure on charitable |
activities | 5 6,7 |
(78,068) | (16,000) | (94,068) | (523) (53,263) |
|
| Total expenditure | (78,068) | (16,000) | (94,088) | (53,786) | |||
| Net income and net movement | in funds | 406,538 | 406,538 | 19,484 | |||
| Reconciliation offunds |
|||||||
| Total funds brought forward |
112,980 | 4,811 | 117,791 | 98,307 | |||
| Total funds carried forward | 519,518 | 4,811 | 524,329 | 117,791 |
| Statem | ent | ofFinancial Po | sition | ||||
|---|---|---|---|---|---|---|---|
| 5 | April 2021 | ||||||
| 2021 | 2020 | ||||||
| Note | |||||||
| Current assets | |||||||
| Cash at bank and | in | hand | 525,649 | 119,111 | |||
| Creditors: amounts | falling due within | ||||||
| one year | 15 | (1,320) | (1,320) | ||||
| Net current assets | 524,329 | 117,791 | |||||
| Total assets less | current liabilities | 524,329 | 117,791 | ||||
| Net assets | 524,329 | 117,791 | |||||
| Funds ofthe charity | |||||||
| Restricted funds |
4,811 | 4,811 | |||||
| Unrestricted funds |
519,518 | 112,980 | |||||
| Total charity funds | 16 | 524,329 | 117,791 |
| Yea | r ended 5April 202 | 1 | |||
|---|---|---|---|---|---|
| 2021 | 2020 | ||||
| f. | |||||
| Cash flows from operating | activities | ||||
| Net income | 406,538 | 19,484 | |||
| Adjustments for: |
|||||
| Cash generated | from operations | 406,538 | 19,484 | ||
| Net cash from operating activities |
406,538 | 19,484 | |||
| Net increase in Cash and cash |
cash and cash equivalents equivalents at beginning |
ofyear | 406,538 119,111 |
19,484 99,627 |
|
| Cash and cash | equivalents | at end ofyear | 525,649 | 119,111 |
| Donations | and leg | acies | ||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total Funds | ||||
| Funds | Funds | 2021 | ||||
| F | F | F | ||||
| Donations | ||||||
| Donations | received | - charitable | purposes | 482,840 | 16,000 | 498,840 |
| Donations | received | —fundraising | ||||
| Donations | received | - overheads | 1,766 | 1,766 | ||
| Donations | received | - gift aid | ||||
| 484,606 | 16,000 | 500,606 | ||||
| Unrestricted | Restricted | Total Funds | ||||
| Funds | Funds | 2020 | ||||
| Donations | ||||||
| Donations | received | - charitable | purposes | 64,850 | 6,029 | 70,879 |
| Donations | received | —fundraising | 523 | 523 | ||
| Donations | received | - overheads | 1,793 | 1,793 | ||
| Donations | received | - gift aid | 75 | 75 | ||
| 67,241 | 6,029 | 73,270 |
| Costs of raising donation | s and legacies |
||||
|---|---|---|---|---|---|
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2021 | Funds | 2020 | ||
| F | |||||
| Costs of raising donations | and legacies- | ||||
| Donations | 523 | 523 |
| Unrestricted | Restricted | Total Funds | ||||
|---|---|---|---|---|---|---|
| Funds | Funds | 2021 | ||||
| Cancer and cardiovascular research activities Food security and agricultural research Bacterial research Obesity research Educational support Reproduction research |
F 12,528 2,000 6,700 7,912 31,156 |
16,000 | 28,528 2,000 6,700 7,912 31,156 |
|||
| Neuroscience research Support costs |
15,917 1,855 |
15,917 1,855 |
||||
| 78,068 | 16,000 | 94,068 | ||||
| Unrestricted | Restricted | Total Funds | ||||
| Funds | Funds | 2020 | ||||
| Cancer and cardiovascular research activities Food security and agricultural research Bacterial research Obesity research |
7,893 13,800 |
6,029 2,000 |
6,029 7,893 15,800 |
|||
| Educational support Reproduction research Neuroscience research |
13,686 7,988 |
13,686 7,988 |
||||
| Support costs | 1,867 | 1,867 | ||||
| 45,234 | 8,029 | 53,263 |
| Expenditure on charitable |
activities b |
y activity type | ||||
|---|---|---|---|---|---|---|
| Grant funding ofactivities |
Support costs | Total funds 2021 |
Total fund 2020 |
|||
| Cancer and cardiovascular | research | F | ||||
| activities Food security and agricultural Bacterial research Obesity research Educational support Reproduction research Neuroscience research Governance costs |
research | 28,528 2,000 6,700 7,912 31,156 15,917 |
1,855 | 28„528 2,000 6,700 7,912 31,156 15,917 1,855 |
6,029 7,893 15,800 13,686 7,988 1,867 |
|
| 92,213 | 1,855 | 94,068 | 53,263 |
| Notes to the F Year |
inancial Statements ended 5 April 2021 |
(continued) | |
|---|---|---|---|
| Analysis ofgrants | |||
| 2021 | 2020 | ||
| f. | |||
| Grants to individuals Cancer and cardiovascular research activities Food security and agricultural research activities Bacterial research activities Obesity research activities Educational support Reproduction research activities Neurosciences research activities |
28,528 2,000 6,700 7,912 31,156 15,917 |
6,029 7,893 15,800 13,686 7,988 |
|
| 92,213 | 51,396 | ||
| 92,213 | 51,396 |
the School of Life Sciences |
the School of Life Sciences |
. | ||||
|---|---|---|---|---|---|---|
| . | Support costs | |||||
| 2021 | 2020 | |||||
| Accountancy | fees | 1,379 90 |
1,320 74 |
|||
| Bank charge | 386 | 355 | ||||
| Computer costs | 118 | |||||
| Printing, postage and stationery |
1,855 | 1,867 | ||||
| 10. | Independent | examination | fees | |||
| 2021 | 2020 | |||||
| f | ||||||
| Fees payable Independent |
to the independent examination ofthe |
examiner for: financial statements |
1,320 | 1,320 |
| Website | ||
|---|---|---|
| development | ||
| Cost | ||
| At 6April | 2020 and 5April 2021 | 3,208 |
| Amortisation | ||
| At 6April | 2020 and 5April 2021 | 3,208 |
| Carrying | amount | |
| At 5April | 2021 | |
| At 5April | 2020 |
| Tangible | fixed asset | s | ||
|---|---|---|---|---|
| Equipment | Total | |||
| E | ||||
| Cost | ||||
| At 6April | 2020 and 5April 2021 | 409 | 409 | |
| Depreciation | ||||
| At 6April | 2020 and 5April 2021 | 409 | 409 | |
| Carrying | amount | |||
| At 5April | 2021 | |||
| At 5 April | 2020 | |||
| Creditors: amounts | falling due within one year | |||
| 2021 | 2020 | |||
| F | ||||
| Accruals and deferred | income | 1,320 | 1,320 |
| Unrestricted | funds | |||||||
|---|---|---|---|---|---|---|---|---|
| At | ||||||||
| At | 6 | April 2020 | Income | Expenditure | 5April 2021 | |||
| F | E | |||||||
| Unrestricted | Fund | 112,980 | 484,606 | (78,068) | 519,518 | |||
| At | 6 | April 2019 | Income | Expenditure | At | 5 April 2020 | ||
| Unrestricted | Fund | 91,496 | 67,241 | (45,757) | 112,980 |
| At | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At 6 April 2020 | Income | Expenditure | 5April 2021 | |||||||||
| F | F | F | ||||||||||
| Restricted | Fund | 4,811 | 16,000 | (16,000) | 4,811 | |||||||
| At 6 April 2019 | Income | Expenditure At 5 April 2020 |
||||||||||
| F | F | F | ||||||||||
| Restricted | Fund | 6,811 | 6,029 | (8,029) | 4,811 | |||||||
| Restricted | funds relate to donations | received for the purposes | of | supporting | particular research areas |
|||||||
| At 5 April | 2020, the | charity | held Restricted | Funds for the | following | purposes: 2021 |
2020 | |||||
| F | F | |||||||||||
| Cancer and cardiovascular | research | 4,811 | 4,811 | |||||||||
| 17. | Analysis | ofnet assets between funds | ||||||||||
| Unrestricted | Restricted | Total Funds | ||||||||||
| Funds | Funds | 2021 | ||||||||||
| F | f. | |||||||||||
| Current assets | 520,838 | 4,811 | 525,649 | |||||||||
| Creditors | less than | 1 | year | (1,320) | (1,320) | |||||||
| Net assets | 519,518 | 4,811 | 524,329 | |||||||||
| Unrestricted | Restricted | Total Funds | ||||||||||
| Funds | Funds | 2020 | ||||||||||
| F | F | |||||||||||
| Current assets | 114,300 | 4,811 | 119,111 | |||||||||
| Creditors | less than | 1 | year | (1,320) | (1,320) | |||||||
| Net assets | 112,980 | 4,811 | 117,791 | |||||||||
| 18. | Analysis | ofchanges | in | net debt | ||||||||
| At | 6Apr 2020 | Cash flows | At 5Apr 2021 | |||||||||
| F | F | F | ||||||||||
| Cash at | bank and | in | hand | 119,111 | 406,538 | 525,649 |